Mark S. Elliott
2021 - PURE Bioscience
In 2021, Mark S. Elliott earned a total compensation of $189K as Vice President Finance at PURE Bioscience, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $27,000 |
|---|---|
| Salary | $162,000 |
| Total | $189,000 |
Elliott received $162K in salary, accounting for 86% of the total pay in 2021.
Elliott also received $27K in option awards.
Rankings
In 2021, Mark S. Elliott's compensation ranked 12,017th out of 12,415 executives tracked by ExecPay. In other words, Elliott earned more than 3.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,017 out of 12,415 | 3rd |
Division Manufacturing | 5,309 out of 5,501 | 4th |
Major group Chemicals And Allied Products | 2,311 out of 2,371 | 3rd |
Industry group Miscellaneous Chemical Products | 32 out of 33 | 3rd |
Source: SEC filing on December 20, 2021.
Elliott's colleagues
We found two more compensation records of executives who worked with Mark S. Elliott at PURE Bioscience in 2021.
News
PURE Bioscience Executive Vice President of Technology & Development Tom Myers' 2023 pay rises 19% to $237K
January 10, 2024
PURE Bioscience COO Tom Myers' 2022 pay slips 13% to $200K
December 23, 2022
PURE Bioscience COO Tom Myers' 2021 pay falls 57% to $231K
December 20, 2021
cbdMD CEO Martin Sumichrast's 2020 pay jumps 44% to $727K
January 25, 2021
PURE Bioscience COO Tom Myers' 2020 pay jumps 62% to $535K
December 8, 2020
cbdMD CEO Martin Sumichrast's 2019 pay rises 7% to $504K
March 11, 2020
cbdMD CFO Mark Elliott's 2018 pay jumps 221% to $784K
March 21, 2019
PURE Bioscience CEO Henry Lambert's 2018 pay falls 60% to $428K
December 20, 2018